Glenmark Pharmaceuticals Inc., USA Nebivolol Tablets, 20 mg, 90 Tablets recall: Cross Contamination with Other Products
Cross Contamination with Other Products
The hazard: Drug safety concern
The product was withdrawn from distribution. Whether your own pack is affected comes down to the lot number.
What the notice says: Cross Contamination with Other Products
Why it matters: The FDA recorded an enforcement action against this product. The classification and the summary above describe how serious the agency considers it.
Recall details
- Recall number
- D-0222-2026
- Published
- December 17, 2025
- Risk level
- Class III
- Status
- Ongoing
- Issued by
- U.S. Food and Drug Administration
- Brand
- Glenmark Pharmaceuticals Inc., USA
- Product type
- Prescription & OTC drugs
- Units affected
- 672 90-count bottles
- Distribution
- Nationwide
- Made in
- United States
- Lot / code info
- Lot# 17240988; Exp. 05/31/2026
Products covered by this recall
Nebivolol Tablets, 20 mg, 90 Tablets, Rx Only, Manufactured by: Glenmark Pharmaceuticals Limited, Pithampur, Madhya Pradesh 454775, India, Manufactured for Avkare, Pulaski, TN 38478, Product of Italy, NDC 42291-874-90.
Check your product
The notice names 6 codes you can read straight off the package. Type the one printed on yours and the list below narrows to it.
Lot or batch code
Usually ink-stamped near the seam, the cap or the bottom of the pack.
- 17240988
Best-by / use-by date
Printed beside the lot code, not on the price sticker.
- 05
- 31
NDC number
On the carton and again on the bottle or blister label.
- 42291-874-90
Package size
Match the net weight or the piece count on the front of the pack.
- 20 mg
- 90 count
Codes are lifted verbatim from the FDA — Drug enforcement notice. A code that is missing here may still be covered — the official notice is the complete list.
What to do about Drug safety
Glenmark Pharmaceuticals Inc., USA — The product was withdrawn from distribution. Whether your own pack is affected comes down to the lot number.
- Check the lot number on your pack against the codes listed above.
- Report side effects you think the product caused to FDA MedWatch.
- Do not stop a prescribed medicine on your own — speak to your prescriber or pharmacist first.
- Ask the dispensing pharmacy for a replacement from an unaffected lot.
What the company owes you
A recalled medicine is the manufacturer’s cost to carry, not yours or your pharmacist’s.
- The purchase price or co-pay is refundable, and so is the cost of returning the product if they ask you to ship it.
- Ask the pharmacy to handle the claim where they can — they process recall returns in bulk and it saves you the correspondence.
- Keep the carton, the leaflet and the pharmacy label together until the claim is closed.
- Costs beyond the price of the medicine need to go to the company directly, in writing, with the recall number quoted.
Company contact: Glenmark Pharmaceuticals Inc., USA — 750 Corporate Dr, Mahwah, NJ, 07430-2009
The official notice
This page summarises a notice published by U.S. Food and Drug Administration. The agency notice is the authoritative version — read it before you act, and treat it as the final word if anything here looks different.
Open the FDA — Drug enforcement record U.S. Food and Drug Administration recalls
Questions people ask about this recall
Why was Glenmark Pharmaceuticals Inc., USA prescription & otc drugs recalled?
Cross Contamination with Other Products Cross Contamination with Other Products
How do I know if I have the recalled product?
Match the codes printed on your package against the notice: lot code 17240988; best-by date 05 or 31. If the code on your package is not on that list, your unit is outside the recall.
What should I do with it right now?
Check the lot number on your pack against the codes listed above.
Can I get my money back?
The purchase price or co-pay is refundable, and so is the cost of returning the product if they ask you to ship it.
Where was the recalled product sold?
It was distributed nationwide.
Related recalls
-
Class II · 3 months ago
Glenmark Pharmaceuticals Inc., USA Azelaic Acid Gel, 15%, 50 gram tubes recall: CGMP Deviations: Product quality complaints concerning abnormal texture
CGMP Deviations: Product quality complaints concerning abnormal texture or consistency (described as grainy, gritty, or sandy) were received.
-
Class II · 4 months ago
Glenmark Pharmaceuticals Inc., USA Alyacen 7/7/7 recall: Failed Impurities/Degradation Specifications: This recall is being initiated
Failed Impurities/Degradation Specifications: This recall is being initiated due to out-of-specification results total impurities.
-
Class II · 10 months ago
Glenmark Pharmaceuticals Inc., USA Ondansetron Orally Disintegrating Tablets recall: Defective container: Preferred Pharmaceuticals received a letter
Defective container: Preferred Pharmaceuticals received a letter from the manufacturer Glenmark, that the blister packs are not fully sealed and…
-
Class III · 11 months ago
Glenmark Pharmaceuticals Inc., USA Bisoprolol Fumarate and Hydrochlorothiazide recall: Cross Contamination with Other Products: Testing of reserve samples showed
Cross Contamination with Other Products: Testing of reserve samples showed presence of traces of ezetimibe
-
Class II · 1+ years ago
Glenmark Pharmaceuticals Inc., USA Viorele, Desogestrel and Ethinyl Estradiol, USP recall: Failed Impurities/Degradation Specifications
Failed Impurities/Degradation Specifications
-
Class II · 1+ years ago
Glenmark Pharmaceuticals Inc., USA Azelaic Acid Gel, 15%, 50 grams recall: CGMP Deviations: Market complaints received for gritty texture (grainy)
CGMP Deviations: Market complaints received for gritty texture (grainy)